1. 000216 ABERRANT P53 IMMUNOSTAINING AS A PROGNOSTIC FACTOR IN EPITHELIAL OVARIAN CANCER; THE IMPACT OF METHODOLOGY. (1st September 2005) Authors: De Graeff, P.; Hall, J.; Crijns, A. P.G.; De Bock, G. H.; Gifford, G.; Paul, J.; De Jong, S.; Bartlett, J. M.; Brown, R.; J. Van Der Zee, A. G. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ONE-YEAR MORTALITY IN ONCO-GERIATRIC PATIENTS IS HIGH. (November 2019) Authors: Festen, S.; Van Der Wal Huisman, H.; Van Der Leest, A.; Reyners, A.K.; De Bock, G.H.; Van Leeuwen, B.L.; De Graeff, P. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Testing the Oncologic Outcome Prioritization Tool in older patients with cancer. (October 2022) Authors: Seghers, P.A.L.; Hamaker, M.E.; De Graeff, P.; Festen, S. Journal: Journal of geriatric oncology Issue: Volume 13(2022)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗